BBS-Bioactive Bone Substitutes Oyj (BONEH) - Cash Flow Conversion Efficiency

Latest as of June 2024: -0.416x

Based on the latest financial reports, BBS-Bioactive Bone Substitutes Oyj (BONEH) has a cash flow conversion efficiency ratio of -0.416x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.58 Million ≈ $-1.84 Million USD) by net assets (€3.79 Million ≈ $4.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BONEH company net worth for the company's overall valuation and market capitalisation.

BBS-Bioactive Bone Substitutes Oyj - Cash Flow Conversion Efficiency Trend (2015–2023)

This chart illustrates how BBS-Bioactive Bone Substitutes Oyj's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BBS-Bioactive Bone Substitutes Oyj share price for real-time trading data and today's change.

BBS-Bioactive Bone Substitutes Oyj Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BBS-Bioactive Bone Substitutes Oyj ranked by their cash flow conversion efficiency. Review how financially flexible is BBS-Bioactive Bone Substitutes Oyj to assess the company's free cash flow relative to its total liabilities.

Company	Cash Flow Conversion Efficiency
Avidian Gold Corp V:AVG	-0.008x
INCUVO S.A. ZY -50 F:68X	0.135x
Next Biometrics Group ASA OL:NEXT	-1.469x
BELGRAVIA HARTFORD CAP. F:ECA	1.398x
Impax Asset Management Group Plc LSE:IPX	0.186x
WILDCAT PRETR.LS -000028 F:8Y6	N/A
Heritage Distilling Holding Company, Inc. NASDAQ:IPST	-0.076x
ILYA Co. Ltd KQ:058450	-0.054x

Annual Cash Flow Conversion Efficiency for BBS-Bioactive Bone Substitutes Oyj (2015–2023)

The table below shows the annual cash flow conversion efficiency of BBS-Bioactive Bone Substitutes Oyj from 2015 to 2023. Also see BBS-Bioactive Bone Substitutes Oyj total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	€5.11 Million ≈ $5.97 Million	€-2.92 Million ≈ $-3.42 Million	-0.572x	+13.21%
2022-12-31	€4.27 Million ≈ $4.99 Million	€-2.82 Million ≈ $-3.29 Million	-0.659x	+4.93%
2021-12-31	€3.63 Million ≈ $4.25 Million	€-2.52 Million ≈ $-2.95 Million	-0.693x	-74.58%
2020-12-31	€6.09 Million ≈ $7.12 Million	€-2.42 Million ≈ $-2.83 Million	-0.397x	+15.30%
2019-12-31	€3.08 Million ≈ $3.60 Million	€-1.44 Million ≈ $-1.69 Million	-0.469x	-21.77%
2018-12-31	€4.42 Million ≈ $5.16 Million	€-1.70 Million ≈ $-1.99 Million	-0.385x	+61.34%
2017-12-31	€1.08 Million ≈ $1.26 Million	€-1.08 Million ≈ $-1.26 Million	-0.996x	-738.64%
2016-12-31	€4.60 Million ≈ $5.37 Million	€-546.00K ≈ $-638.33K	-0.119x	-23.33%
2015-12-31	€4.46 Million ≈ $5.22 Million	€-430.00K ≈ $-502.72K	-0.096x	--

About BBS-Bioactive Bone Substitutes Oyj

HE:BONEH Finland Medical Devices

Market Cap

$1.76 Million

€1.50 Million EUR

Market Cap Rank

#30401 Global

#150 in Finland

Share Price

€0.05

Change (1 day)

+0.00%

52-Week Range

€0.05 - €0.05

All Time High

€9.68